An Extension Protocol for Patients Who Previously Completed the TMS Pilot Study

For non responders and partial responders: Inclusion Criteria: * Completion of the study #8116 (NCT05319080) * The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnosis of schizophrenia or schizoaffective disorder * A reduction of AHRS less than 50% of the initial score * Capacity and willingness to provide informed consent * If female and not infertile, must agree to use one of the following forms of contraception for the duration of study participation: systemic hormonal treatment, an intrauterine device (IUD) which was implanted at least 2 months prior to screening, or "double-barrier" contraception. Women of child bearing potential must have a negative pregnancy test at screening * Right handed * Normal hearing * Taking an antipsychotic medication at a stable dose for at least 4 weeks. All oral and depot antipsychotics are allowable. Exclusion Criteria: * Substance use disorder (excluding nicotine) within last 90 days, or positive toxicology screen for any substance of abuse * Pregnancy * Severe adverse events of TMS * History of seizure, epilepsy and neurologic conditions with structural cerebral damage, including stroke, multiple sclerosis, traumatic brain injury, Alzheimer's and other neurodegenerative diseases, meningoencephalitis or intracerebral abscess, parenchymal or leptomeningeal cancers, dementia, developmental disability, cerebrovascular disease, increased intracranial pressure, or central nervous system (CNS) tumors, brain…